Study of EMB-001 as a Potential Smoking Cessation Treatment

NCT04933916 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Tobacco Use Disorder

Interventions

DRUG: EMB-001

Sponsor

Embera NeuroTherapeutics, Inc.

Collaborators

[object Object]
[object Object]
[object Object]